NEW YORK (GenomeWeb News) – Sony DADC Austria and Singulex today announced a supply agreement for the design and manufacture of customized detection vessels by Sony DADC BioSciences for Singulex's Sgx Clarity System.

Currently under development, Sgx Clarity is an ultrasensitive in vitro diagnostic platform that uses Singulex's proprietary single molecule counting technology. The fully automated system is expected to be able to detect low abundance biomarkers at femtograms per milliliter levels, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.